Status:
NOT_YET_RECRUITING
Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Institute for Advanced Biosciences (IAB), Grenoble
Conditions:
Inflammatory Bowel Disease (IBD)
Eligibility:
All Genders
18+ years
Brief Summary
Inflammatory bowel diseases, Crohn's disease and haemorrhagic rectocolitis, are pathologies that progress in flare-ups, impacting on patients' quality of life and functional or even vital prognosis. T...
Eligibility Criteria
Inclusion
- Men and women over 18
- Managed at the CHUGA for a severe IBD flare-up requiring hospitalisation or endoscopy for flare-up
- Patient not objecting to the REPRO-MICI study
Exclusion
- Patients protected by law (pregnant or breast-feeding women, minors, patients under guardianship or trusteeship, persons deprived of their liberty or hospitalised under duress).
- Patients with positive HIV, HBV or HCV serology.
- Patients with a positive ELISPOT with no history of treatment for latent tuberculosis.
Key Trial Info
Start Date :
May 16 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06944873
Start Date
May 16 2025
End Date
June 30 2027
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble Alpes University Hospital
La Tronche, France, 38700